Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trials
Authors:
- 1 September 2011
- Vol. 150 (3) , 466-473
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA016042, P01AT003960)
This publication has 38 references indexed in Scilit:
- Adjuvant Therapy in Pancreatic CancerDigestive Diseases, 2010
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection PercentagesPLOS Medicine, 2010
- Neoadjuvant therapy of locally advanced gastric cancerJournal of Surgical Oncology, 2010
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2009
- Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic HeadJournal of Clinical Oncology, 2008
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007
- Surgery for Recurrent Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 2007
- Neoadjuvant Therapy in Pancreatic CancerCancer Investigation, 2007
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Transformations Related to the Angular and the Square RootThe Annals of Mathematical Statistics, 1950